PTGER4 and neoplasm: Thus, synergistic antimetastatic activity via inhibition of sEH and EP4 may be a host-directed therapeutic approach to enhance the endogenous clearance of tumor cell debris and address the intrinsic limitation of cytotoxic cancer therapy.